
    
      Following angiography, patients with significant diameter stenosis > 50% and lesion length (>
      50mm) requiring at least 2 multiple long-stent placement by visual estimation and eligible
      for LONG-DES VI trial inclusion and exclusion criteria will be randomized 1:1 to
      zotarolimus-eluting stent (Resolute Integrity or Resolute Onyx stent) or everolimus-eluting
      stent (Xience Prime or Xience Xpedition or Xience Alpine stent) by the stratified
      randomization method.
    
  